Bridgeway Capital Management’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-530
| Closed | -$4.2K | – | 1298 |
|
|
2024
Q2 | $4.2K | Hold |
530
| – | – | ﹤0.01% | 1263 |
|
|
2024
Q1 | $7.18K | Sell |
530
-1,400
| -73% | -$19K | ﹤0.01% | 1302 |
|
|
2023
Q4 | $20.9K | Hold |
1,930
| – | – | ﹤0.01% | 1339 |
|
|
2023
Q3 | $12.5K | Sell |
1,930
-2,000
| -51% | -$13K | ﹤0.01% | 1353 |
|
|
2023
Q2 | $70.7K | Sell |
3,930
-7,138
| -64% | -$128K | ﹤0.01% | 1301 |
|
|
2023
Q1 | $260K | Sell |
11,068
-2,000
| -15% | -$47K | 0.01% | 1050 |
|
|
2022
Q4 | $327K | Sell |
13,068
-2,000
| -13% | -$50K | 0.01% | 972 |
|
|
2022
Q3 | $479K | Hold |
15,068
| – | – | 0.01% | 907 |
|
|
2022
Q2 | $595K | Hold |
15,068
| – | – | 0.01% | 842 |
|
|
2022
Q1 | $606K | Hold |
15,068
| – | – | 0.01% | 891 |
|
|
2021
Q4 | $761K | Sell |
15,068
-600
| -4% | -$30.3K | 0.01% | 853 |
|
|
2021
Q3 | $1.02M | Hold |
15,668
| – | – | 0.02% | 819 |
|
|
2021
Q2 | $607K | Buy |
15,668
+2,100
| +15% | +$81.4K | 0.01% | 1015 |
|
|
2021
Q1 | $712K | Sell |
13,568
-7,874
| -37% | -$413K | 0.01% | 989 |
|
|
2020
Q4 | $1.46M | Buy |
21,442
+4,530
| +27% | +$308K | 0.03% | 633 |
|
|
2020
Q3 | $648K | Buy |
16,912
+2,612
| +18% | +$100K | 0.01% | 806 |
|
|
2020
Q2 | $553K | Buy |
14,300
+7,500
| +110% | +$290K | 0.01% | 822 |
|
|
2020
Q1 | $204K | Hold |
6,800
| – | – | ﹤0.01% | 1053 |
|
|
2019
Q4 | $772K | Hold |
6,800
| – | – | 0.01% | 805 |
|
|
2019
Q3 | $214K | Hold |
6,800
| – | – | ﹤0.01% | 1172 |
|
|
2019
Q2 | $291K | Hold |
6,800
| – | – | ﹤0.01% | 1106 |
|
|
2019
Q1 | $371K | Buy |
+6,800
| New | +$371K | ﹤0.01% | 1109 |
|
|
2018
Q2 | – | Sell |
-3,780
| Closed | -$145K | – | 1440 |
|
|
2018
Q1 | $145K | Hold |
3,780
| – | – | ﹤0.01% | 1296 |
|
|
2017
Q4 | $219K | Buy |
3,780
+2,500
| +195% | +$145K | ﹤0.01% | 1268 |
|
|
2017
Q3 | $84K | Sell |
1,280
-1,220
| -49% | -$80.1K | ﹤0.01% | 1354 |
|
|
2017
Q2 | $211K | Buy |
+2,500
| New | +$211K | ﹤0.01% | 1279 |
|